Reference number : 236-2011-2012-Q1-00409, amendment number : , agreement type : G, recipient legal name : PRENTKI, Marc, recipient country : CA, recipient province : QC, recipient city : Montréal, recipient postal code : H2X 0A9, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 157925.0, agreement start date : 2011-10-01, agreement end date : 2012-09-30, description english : Validation of a glycerolipid/ free fatty acid cycling enzyme as a novel therapeutic target for type-2 diabetes, description french : Validation of a glycerolipid/ free fatty acid cycling enzyme as a novel therapeutic target for type-2 diabetes, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2011-12 to 2012-13), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2011-12 à 2012-13), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada